SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-017505
Filing Date
2022-06-22
Accepted
2022-06-22 16:55:55
Documents
2
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3825
2 ex24.htm EX-24 8678
  Complete submission text file 0001493152-22-017505.txt   13962
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Issuer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2042 CORTE DEL NOGAL SUITE B CARLSBAD CA 92011
Business Address
Poirier Michael S. (Reporting) CIK: 0001812504 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37428 | Film No.: 221032656